Resistance Training in Intradialysis Patients (DIAPRE)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Mr. Baskaran Chandrasekaran, Sikkim Manipal University
ClinicalTrials.gov Identifier:
NCT01065389
First received: February 4, 2010
Last updated: September 8, 2013
Last verified: September 2013

February 4, 2010
September 8, 2013
October 2010
April 2015   (final data collection date for primary outcome measure)
Serum and Urea biochemistry - electrolytes (Na, K+), serum albumin, inflammatory markers, urea kinetics, protein catabolic rate [ Time Frame: Bimonthly ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01065389 on ClinicalTrials.gov Archive Site
  • Maximal Oxygen Consumption (VO2 max) and Heart Rate Recovery through Queens College step test [ Time Frame: Once Monthly ] [ Designated as safety issue: No ]
  • Fat levels by skin fold measurements [ Time Frame: Once monthly ] [ Designated as safety issue: No ]
  • Handgrip strength by dynamometer [ Time Frame: Once monthly ] [ Designated as safety issue: No ]
  • Six minute walk test distance [ Time Frame: Once monthly ] [ Designated as safety issue: No ]
  • Quality of life (KDQOL - SF questionnaire) [ Time Frame: Once monthly ] [ Designated as safety issue: No ]
  • Depression (Beck Depression Questionnaire) [ Time Frame: Once monthly ] [ Designated as safety issue: No ]
  • Lactate Threshold [ Time Frame: Once monthly ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Resistance Training in Intradialysis Patients
Phase 1 RCT of Progressive Resistance Training on Small Solute Clearance, Functional Capacity and Quality of Life in Intradialysis Patients

Dialysis patients usually have peripheral muscle weakness due to metabolic disturbances (increased protein catabolism) and fatigue. This muscle weakness may decrease functional capacity and quality of life. It also serves to increase cardiovascular risk factors in these end stage renal disease patients. Peripheral muscle strength training shall combat physical inactivity during dialysis. In the investigators trial, the investigators hypothesis that peripheral muscle training might regulate protein catabolic rate,renal functions, cardiovascular risk factors, improve functional capacity and quality of life in endstage renal disease patients undergoing dialysis.

End stage renal failure patients undergoing dialysis have profound muscle wasting, reduced functional capacity and quality of life due to uremia, steroids, frequent dialysis and fatigue. During dialysis, physical inactivity further deteriorates the patient's functional capacity. Aerobic or strength training may combat this physical inactivity. It may also improve the functional capacity and quality of life. Recent studies have claimed the benefits of resistance exercises in improving functional capacity. But they have not documented effects on kidney function (electrolyte and urea kinetics) and muscle wasting (protein catabolic rate). In our trial, we attempt to study the effects of resistance training in improvement of renal function and muscle wasting apart from functional capacity and quality of life in dialysis patients

Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Pharmacokinetics/Dynamics Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
  • Dialysis
  • End Stage Renal Disease
  • Behavioral: Progressive Resistance Exercise Training
    Progressive Resistance Exercise Training thrice a week for 12 weeks. For first two weeks, 60% of 5 repetition maximum, progressing at 5% of 5 repetition maximum each week reaching upto 110% of 5 Repetition maximum at the end of 12 weeks
    Other Name: Strength Training
  • Behavioral: Unstructured Nonprogressive resistance exercise
    Unstructured Resistance Exercise 30 minutes a day, thrice a week for 12 weeks. For 12 weeks, 20% 5 repetition maximum (which will not induce training effect and any physiological responses)and free range of motion exercises with no progression.
    Other Name: Non progressive strength training
  • Experimental: Prgressive Resistance Exercise Training
    Progressive Resistance Exercise Training thrice a week for 12 weeks. For first two weeks, 60% of 5 repetition maximum, progressing at 5% of 5 repetition maximum each week reaching upto 110% of 5 Repetition maximum at the end of 12 weeks
    Intervention: Behavioral: Progressive Resistance Exercise Training
  • Active Comparator: Unstructured Resistance Exercise
    Unstructured Resistance Exercise thrice a week for 12 weeks. For 12 weeks, 20% 5 repetition maximum (which will not induce training effect and any physiological responses)and free range of motion exercises with no progression.
    Intervention: Behavioral: Unstructured Nonprogressive resistance exercise
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
46
August 2016
April 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Must have end stage renal disease (diagnosed and the stage graded by nephrologist or the intensivist concerned) for more than 6 months and dialysis for at least 3 months (the impact of exercise training can be easily assessed)
  • Must be between the ages of 30 - 60 years of age/ both genders.
  • Must be able to understand the purpose of exercise testing and resistance training.

Exclusion Criteria:

  • Those with acute nephritic syndrome and hematuria < 2 months.
  • Those with profound anemia and blood transfusion < 2 months
  • Those underwent renal transplantation < 6 months.
  • Those receiving/ received cytotoxic drugs - amiloride, azathioprine/ aspirin (antiplatelets)< 2 months
  • Those with coagulation disorders or under anticoagulants < 4 months.
  • Those underwent recent cardiac surgeries and with recent unstable cardiac failures
  • Those with recent cerebrovascular accidents < 6 months
  • Those have recent urinary tract infections, Renal and bladder carcinomas < 2 months
  • Those with absolute contraindications for resistance exercise training (as per American College of Sports Medicine.
Both
30 Years to 60 Years
No
Contact information is only displayed when the study is recruiting subjects
India
 
NCT01065389
CTRI/2010/091/000014
Yes
Mr. Baskaran Chandrasekaran, Sikkim Manipal University
Sikkim Manipal University
Not Provided
Principal Investigator: Baskaran Chandrasekaran, MPT Lecturer / Consultant cardiopulmonary Physiotherapist
Study Chair: Bidhan C Sharma, MPT Assistant Professor/ Consultant Physiotherapist
Study Chair: Manish Goon, BPT Clinical Physiotherapist
Study Chair: Nikita Joshi, MPT Head of Department/ Associate Professor
Study Chair: Arpan Battacharia, MD Dialysis Unit Incharge
Study Director: Bidita Kandelwal, MD Head of Medicine Department
Sikkim Manipal University
September 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP